Tower Research Capital LLC (TRC) - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 44 filers reported holding ONCOLYTICS BIOTECH INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q2 2023$6,861
+36010.5%
2,639
-83.5%
0.00%
-100.0%
Q1 2023$19
+111.1%
16,017
+185.3%
0.00%
Q4 2022$9
-99.8%
5,615
+47.3%
0.00%
Q3 2022$5,000
-16.7%
3,813
-38.7%
0.00%
Q2 2022$6,000
+200.0%
6,222
+557.0%
0.00%
Q1 2022$2,000
-33.3%
947
-44.7%
0.00%
Q4 2021$3,000
-50.0%
1,714
-20.6%
0.00%
Q2 2021$6,0002,160
+3500.0%
0.00%
Q3 2020$0600.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q2 2021
NameSharesValueWeighting ↓
Verition Fund Management LLC 408,838$695,0000.02%
Magnus Financial Group LLC 10,000$17,0000.00%
SCOTIA CAPITAL INC. 48,039$83,0000.00%
HUNTINGTON NATIONAL BANK 1,052$2,0000.00%
BANK OF AMERICA CORP /DE/ 367$1,0000.00%
WELLS FARGO & COMPANY/MN 642$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HOWE & RUSLING INC 105$00.00%
1832 Asset Management L.P. 5$00.00%
DEUTSCHE BANK AG\ 4,601$7,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders